• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. SFX SYM PDS+ UNI VIO 18IN 0 S/A CT-2; SUTURE, SURGICAL, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. SFX SYM PDS+ UNI VIO 18IN 0 S/A CT-2; SUTURE, SURGICAL, ABSORBABLE Back to Search Results
Model Number SXPP1A407
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/03/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that a patient underwent an unknown procedure on an unknown date and the suture was used.It was reported that the suture broke.There were no adverse patient consequences reported.Additional information has been requested.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).This is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Ramjmsd was provided in the report, however it is not a valid lot in the system.Additional information was requested and the following was obtained: when was the suture breakage (in the package, during removal from package, during handling prior to use on patient or during use on the patient)? please specify.Device return status? ramjmsd is not a valid lot in the system, please provide the correct lot number.What date did the event occur? in what procedure did the event occur? the icare was created (b)(6) 2022 and on the icare states that no harm to patient and suture kept breaking out of patient.Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Trade name - irgacare®.Active ingredient(s) ¿ triclosan.Dosage form ¿ suture/solid/parenteral.Strength ¿ = 2360 g/m.Events reported via 2210968-2022-07090, 2210968-2022-07092, 2210968-2022-07093, and 2210968-2022-07094.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Date sent to the fda: 9/22/2022.This is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information was requested, the following was obtained: suture breakage was in the package, device return status is ready to go.Lot# lk7038.This surgery took place (b)(6) 2022.Procedure: vaginal hysterectomy & posterior repair.Trade name - irgacare®.Active ingredient(s) ¿ triclosan.Dosage form ¿ suture/solid/parenteral.Strength ¿ = 2360 g/m.Events reported via 2210968-2022-07090, 2210968-2022-07091, 2210968-2022-07092, 2210968-2022-07093, and 2210968-2022-07094.
 
Additional Manufacturer Narrative
(b)(4).Date sent to the fda: 10/31/2022.This is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SFX SYM PDS+ UNI VIO 18IN 0 S/A CT-2
Common Device Name
SUTURE, SURGICAL, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-JUAREZ
avenida de las torres 7125
col salvacar
ciudad juarez 32604
MX   32604
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
9083863534
MDR Report Key15324279
Report Number2210968-2022-07091
Device Sequence Number5505746
Product Code NEW
UDI-Device Identifier10705031227644
UDI-Public10705031227644
Combination Product (Y/N)Y
Initial Reporter CountryUS
PMA/510(K) Number
K113004
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Distributor
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date (Section B) 10/31/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/31/2022
Device Model NumberSXPP1A407
Device Catalogue NumberSXPP1A407
Device Lot NumberLK7038
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/16/2022
Supplement Date Received by Manufacturer09/15/2022
10/06/2022
Initial Report FDA Received Date08/30/2022
Supplement Report FDA Received Date09/23/2022
10/31/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured09/08/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-